Alyeska Investment Group
DOVA

Alyeska Investment Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Alyeska Investment Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50,000
Closed -$1.4M – 537
2019
Q3 		$1.4M Buy
+50,000
New +$810K 0.02% 309
2017
Q3 		– Sell
-35,000
Closed -$780K – 574
2017
Q2 		$780K Buy
+35,000
New +$737K 0.01% 420

Alyeska Investment Group's DOVA Position: Q4 2019 in Review

Alyeska Investment Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 50,000 shares — an estimated $1.4M sold.

Alyeska Investment Group first reported a position in DOVA in Q2 2017 and held it in 2 quarters. The position peaked at $1.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Alyeska Investment Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 50,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.4M.
  • Alyeska Investment Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Alyeska Investment Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.4M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.